Menopause Drugs Market Current Status and Future Prospects | Bayer, Eli Lilly, Abbott, Pfizer

HTF Market Report

Updated · Jun 20, 2023

Menopause Drugs Market Current Status and Future Prospects | Bayer, Eli Lilly, Abbott, Pfizer

Published Via 11Press : Menopause is a natural phase in a woman’s life when her menstrual cycles cease permanently and menopause medicines are pharmaceuticals used to treat the symptoms of this condition. Menopause medications can aid in the relief of symptoms brought on by the hormonal changes that take place during menopause, including hot flashes, vaginal dryness, and mood swings. Hormone treatment (HT), which involves taking oestrogen and/or progesterone to replace the hormones that are depleting in the body, is the most often used menopausal medication. Hormone treatment comes in a variety of forms, such as low-dose vaginal oestrogen therapy, combination estrogen-progestin therapy, and estrogen-only therapy.

Get Free Sample Pages PDF (Including Full TOC, Table & Figures) 👉

Menopause Drugs Market Report Highlights:

Attributes Details
Study Period 2018-2029
Base Year 2022
Forecast Period 2023-2029
Volume Unit K Units
Value Unit USD (Million)
Customization in Scope With the purchase of the Menopause Drugs Market report, get customization. Subject to practicality, you can include or modify a nation, or area, or acquire a more detailed segmentation in the final output.

Major players covered such as:

  • Bayer
  • Eli Lilly
  • Pfizer
  • AbbVie
  • Novo Nordisk
  • Merck KGaA
  • Mylan
  • Teva
  • Novartis
  • Abbott

Breakdown by Application:

  • Hospitals
  • Drugstores

By Type:

  • Parenteral
  • Transdermal
  • Oral

By Menopause Stages:

  • Perimenopause
  • Postmenopause

 Key Developments in the Market:

  • On August 11th, 2020, Bayer added KaNDy Therapeutics, a company located in the United Kingdom, and its experimental menopause medication to its pipeline of women’s healthcare products.
  • The FDA accepted Astellas Pharma Inc.’s New Drug Application (NDA) for an investigational oral, nonhormonal compound seeking approval to treat moderate to severe vasomotor symptoms (VMS) related to menopause, the company announced on August 18, 2022.
  • Menopause symptoms including hot flashes and/or nocturnal sweats are known as VMS.
  • A large number of businesses are fighting for market share in the menopausal medicine industry, which is quite competitive.
  • Bayer is a significant player in the menopausal medication industry with items like Angeliq and Climara.
  • The business specialises in natural cures and non-hormonal therapy like supplements. Imvexxy and Bijuva are only two of the menopausal medications offered by TherapeuticsMD.
  • The business is putting its focus on creating cutting-edge delivery systems, such vaginal implants and combo medicines.
  • There is fierce competition among several businesses for market share in the menopausal medication industry.

Enquire for customization in Report 👉

Regulatory Insights:

  • Before they can be sold, menopause drugs must pass a stringent approval procedure. Companies must conduct clinical trials and other research to prove the safety and effectiveness of their products before they may be sold.
  • Drug safety and possible adverse effects information must be included on the label of menopause drugs.
  • Regulatory agencies must evaluate and approve these labels, and they must be accurate and current.
  • Medication for menopause is subject to advertising and marketing rules that restrict the statements businesses may make about their goods.
  • Companies must be able to support any statements they make regarding their medications, and they cannot use deceptive or fraudulent advertising.

Influencing Trend:

  • The use of non-hormonal treatments for menopausal symptoms is rising. These medications include gabapentin, selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine reuptake inhibitors (SNRIs).
  • The move towards non-hormonal treatments is being driven by worries about the safety of hormone therapy as well as a desire for more natural and holistic approaches to health.
  • Over-the-counter (OTC) menopausal drugs, which may be acquired without a prescription, are becoming more and more popular.
  • Over-the-counter menopausal treatments include herbal therapies, vitamins, and natural supplements.
  • Due to their accessibility and convenience of use, many OTC medications are well-liked, but there are questions regarding their effectiveness and safety.

Market Growth Drivers:

  • The market for pharmaceuticals used to treat menopausal symptoms is known as the “menopause drugs market.”
  • Due to a number of factors, the market for prescription and over-the-counter medications is anticipated to expand in the upcoming years.
  • One of the main factors propelling the market for menopausal medications is the ageing population.
  • Menopause normally happens when women become older, and as the world’s population gets older, more women will likely experience it.
  • Demand for menopause medications is anticipated to increase as more women look for treatment from menopausal symptoms.
  • Another factor driving the demand for menopausal medications is a greater understanding of the condition and its symptoms.

Buy Now Latest Version Report 👉


  • Menopause drugs must pass severe regulatory criteria, including FDA clearance and clinical studies.
  • For smaller enterprises with limited resources, the regulatory procedure may be time-consuming and expensive.
  • Growing concerns concerning the safety of menopause medications, particularly hormonal therapy, are being raised.
  • Hormone replacement treatment (HRT) use has decreased as a result of research showing a relationship between it and a higher risk of heart disease, stroke, and breast cancer.
  • Companies whose menopausal medicine portfolios rely on hormone therapy face a hurdle as a result of this.
  • There is fierce competition among several businesses for market share in the menopausal medication industry.
  • Because major pharmaceutical firms have substantial resources and established market positions, smaller pharmaceutical businesses may find it challenging to compete.


  • The possibility of unfavourable side effects from several menopausal drugs is one of the main limitations.
  • For instance, hormone treatment has been associated with an increased risk of breast cancer, heart disease, and stroke.
  • While hormone therapy has the potential to be an effective treatment for menopausal symptoms, the hazards have prompted many women to look for alternatives or forego menopause drugs altogether.
  • The rising popularity of complementary treatments like herbal medicines and lifestyle modifications is another barrier.
  • The need for menopausal medicines may decline as more women turn to these therapies as a safer and more natural method to manage their symptoms.
  • Cost is also another factor that can limit the market for menopausal medications.


  • As the need for non-hormonal medicines to address menopausal symptoms increases, pharmaceutical companies have a chance to create new, more potent non-hormonal medications.
  • There is now research being done to create medications that target particular problems like hot flashes and vaginal dryness, but there is still an opportunity for more advancement in this field.
  • The field of personalised medicine is expanding quickly, and pharmaceutical companies now have the chance to create menopausal medications and treatments that are customised for specific individuals.
  • Specific health concerns might be identified and individualised treatment regimens could be created using genetic testing and analysis.
  • Alternative treatments for menopausal symptoms, such as acupuncture, yoga, and meditation, are gaining popularity.
  • This presents a chance for supplement development for the pharmaceutical industry.

Contact Us:
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Phone: +1 434 322 0091
[email protected]   

Content has been published via 11press. for more details please contact at [email protected]

HTF Market Report
HTF Market Report

HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited which provides next-generation service for organizations with a deep focus on market intelligence, data analytics, and social intelligence, all uniquely delivered under one roof by skilled professionals. Combining and analyzing acquire lucid and most relevant data which would help in better decision-making. We provide your requirements with speed and cost benefits across the world, and we are able to achieve a more nuanced and comprehensive understanding of the market at the delivery speed and price advantage that today’s business climate demands.

More Posts By HTF Market Report